Summary by Moomoo AI
On May 1, 2024, Diana McKenzie, associated with Vertex Pharmaceuticals Inc. (VRTX), engaged in transactions involving the company's common stock. McKenzie acquired 1,001 shares at no cost, which is typically indicative of a grant or award. On the same day, she disposed of 1,168 shares; however, the transaction price was not disclosed. Following these transactions, McKenzie's direct holdings in Vertex Pharmaceuticals totaled 2,436 shares. Additionally, it was reported that McKenzie holds 207 shares indirectly through a trust. The transactions have been marked as completed.